Vildagliptin Efficacy in Combination with MetfoRmIn for EarlY Treatment of Type 2 Diabetes Mellitus (VERIFY)

被引：0
|
作者：
Sheu, Wayne Huey-Herng [1 ]
Prato, Stefano D. [2 ]
Foley, James [3 ]
Kothny, Wolfgang [4 ]
Kozlovski, Plamen [4 ]
Paldanius, Paeivi [4 ]
Stumvoll, Michael [5 ]
Matthews, David R. [6 ]
机构：
[1] Taichung Vet Gen Hosp, Dept Internal Med, Taichung, Taiwan
[2] Univ Pisa, Dept Endocrinol & Metab, Sect Metab Dis, Pisa, Italy
[3] Novartis Pharmaceut, E Hanover, NJ USA
[4] Novartis Pharma AG, Basel, Switzerland
[5] Univ Leipzig, Dept Med, D-04109 Leipzig, Germany
[6] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2014年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
482
引用
收藏
页码：254 / 255
页数：2
相关论文
共 50 条
  • [41] The use of a combination of metformin and rosiglitazone in type 2 diabetes mellitus
    Demidova, T. Y.
    DIABETES MELLITUS, 2007, 10 (03): : 27 - 31
  • [42] In type 2 diabetes, early metformin plus vildagliptin reduced treatment failure vs a stepwise approach
    Brown, Krysta
    Donato, Anthony A.
    ANNALS OF INTERNAL MEDICINE, 2020, 172 (04) : JC23 - JC23
  • [43] Linagliptin/metformin HCl (fixed combination therapy) for the treatment of Type 2 diabetes mellitus
    Bhargava, Amit
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2015, 10 (04) : 353 - 363
  • [44] Safety and efficacy of metformin up-titration in Japanese patients with type 2 diabetes mellitus treated with vildagliptin and low-dose metformin
    Suzuki, Luka
    Kanazawa, Akio
    Uzawa, Hirotsugu
    Osonoi, Yusuke
    Masuyama, Atushi
    Azuma, Kosuke
    Takeno, Kageumi
    Takayanagi, Naoko
    Sato, Junko
    Someya, Yuki
    Komiya, Koji
    Goto, Hiromasa
    Mita, Tomoya
    Ikeda, Fuki
    Ogihara, Takeshi
    Shimizu, Tomoaki
    Ohmura, Chie
    Saito, Miyoko
    Osonoi, Takeshi
    Watada, Hirotaka
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (18) : 1921 - 1928
  • [45] Efficacy and Safety of Avandamet or Uptitrated Metformin Treatment In Patients With Type 2 Diabetes Inadequately Controlled With Metformin Alone: A Trial of Early Combination Treatment in Diabetes (TREND)
    Ji, Linong
    Lu, Juming
    Hong, Tianpei
    Yang, Wenying
    Zou, Dajin
    Li, Yanbing
    DIABETES, 2013, 62 : A672 - A672
  • [46] Cost effectiveness of vildagliptin versus glimepiride as add-on treatment to metformin for the treatment of diabetes mellitus type 2 patients in Greece
    Hara Kousoulakou
    Magdalini Hatzikou
    Varvara Baroutsou
    John Yfantopoulos
    Cost Effectiveness and Resource Allocation, 15
  • [47] Metabolomics Based on MS in Mice with Diet-Induced Obesity and Type 2 Diabetes Mellitus: the Effect of Vildagliptin, Metformin, and Their Combination
    Tomasova, Petra
    Buganova, Martina
    Pelantova, Helena
    Holubova, Martina
    Sediva, Blanka
    Zelezna, Blanka
    Haluzik, Martin
    Maletinska, Lenka
    Kunes, Jaroslav
    Kuzma, Marek
    APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, 2019, 188 (01) : 165 - 184
  • [48] Metabolomics Based on MS in Mice with Diet-Induced Obesity and Type 2 Diabetes Mellitus: the Effect of Vildagliptin, Metformin, and Their Combination
    Petra Tomášová
    Martina Bugáňová
    Helena Pelantová
    Martina Holubová
    Blanka Šedivá
    Blanka Železná
    Martin Haluzík
    Lenka Maletínská
    Jaroslav Kuneš
    Marek Kuzma
    Applied Biochemistry and Biotechnology, 2019, 188 : 165 - 184
  • [49] An overview of metformin in the treatment of type 2 diabetes mellitus
    Davidson, MB
    Peters, AL
    AMERICAN JOURNAL OF MEDICINE, 1997, 102 (01): : 99 - 110
  • [50] Vildagliptin plus metformin combination therapy provides superior glycaemic control to individual monotherapy in treatment-naive patients with type 2 diabetes mellitus
    Bosi, E.
    Dotta, F.
    Jia, Y.
    Goodman, M.
    DIABETES OBESITY & METABOLISM, 2009, 11 (05): : 506 - 515
12345